X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4458) 4458
Newsletter (319) 319
Publication (277) 277
Newspaper Article (173) 173
Book Review (131) 131
Magazine Article (52) 52
Book Chapter (47) 47
Trade Publication Article (17) 17
Transcript (15) 15
Conference Proceeding (11) 11
Dissertation (3) 3
Reference (3) 3
Web Resource (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aspirin (3833) 3833
humans (3264) 3264
index medicus (2492) 2492
clopidogrel (1814) 1814
male (1623) 1623
female (1536) 1536
platelet aggregation inhibitors - therapeutic use (1517) 1517
ticlopidine - analogs & derivatives (1391) 1391
stroke (1311) 1311
aged (1297) 1297
middle aged (1233) 1233
aspirin - therapeutic use (1224) 1224
cardiac & cardiovascular systems (1184) 1184
risk factors (1004) 1004
drug therapy, combination (978) 978
prevention (915) 915
treatment outcome (914) 914
ticlopidine - therapeutic use (890) 890
drug therapy (763) 763
acute coronary syndromes (751) 751
platelet aggregation inhibitors - adverse effects (738) 738
platelet aggregation inhibitors - administration & dosage (733) 733
heart attacks (706) 706
anticoagulants (689) 689
peripheral vascular disease (685) 685
care and treatment (684) 684
aspirin - administration & dosage (661) 661
antiplatelet therapy (659) 659
risk (643) 643
cardiology (616) 616
thrombosis (601) 601
myocardial-infarction (600) 600
percutaneous coronary intervention (577) 577
mortality (563) 563
aspirin - adverse effects (553) 553
abridged index medicus (552) 552
coronary heart disease (538) 538
pharmacology & pharmacy (538) 538
therapy (535) 535
cardiovascular disease (525) 525
stroke - prevention & control (520) 520
research (519) 519
ticlopidine - administration & dosage (506) 506
warfarin (498) 498
medicine, general & internal (483) 483
secondary prevention (477) 477
stents (476) 476
cardiac patients (468) 468
hematology (461) 461
medicine & public health (457) 457
analysis (449) 449
anticoagulants - therapeutic use (431) 431
blood platelets (430) 430
low-dose aspirin (424) 424
atrial fibrillation (413) 413
aged, 80 and over (412) 412
dosage and administration (409) 409
cardiovascular (408) 408
clinical trials (408) 408
patients (405) 405
ticlopidine - adverse effects (404) 404
hemorrhage - chemically induced (403) 403
adult (394) 394
time factors (381) 381
medical research (372) 372
acute myocardial-infarction (359) 359
trial (352) 352
double-blind (350) 350
cardiovascular diseases (345) 345
risk assessment (342) 342
medicine, experimental (335) 335
platelet aggregation inhibitors - pharmacology (329) 329
health aspects (328) 328
surgery (328) 328
ischemia (326) 326
internal medicine (321) 321
bleeding (309) 309
fibrinolytic agents - therapeutic use (309) 309
aggregation (308) 308
randomized controlled trials as topic (308) 308
studies (299) 299
prospective studies (295) 295
clinical neurology (291) 291
retrospective studies (288) 288
intervention (282) 282
platelet aggregation - drug effects (281) 281
follow-up studies (277) 277
management (275) 275
transient ischemic attack (274) 274
myocardial infarction (270) 270
coronary vessels (269) 269
acute coronary syndrome - drug therapy (268) 268
dual antiplatelet therapy (258) 258
disease (250) 250
metaanalysis (249) 249
anticoagulants - adverse effects (247) 247
hemorrhage (247) 247
dipyridamole (244) 244
aspirin - pharmacology (243) 243
stroke - etiology (243) 243
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4982) 4982
French (33) 33
German (21) 21
Chinese (10) 10
Spanish (9) 9
Korean (8) 8
Japanese (4) 4
Russian (3) 3
Czech (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC: Cardiovascular Interventions, ISSN 1936-8798, 07/2017, Volume 10, Issue 13, pp. 1357 - 1365
Objectives The aim of this study was to compare aspirin plus clopidogrel with aspirin alone as antithrombotic treatment following transcatheter aortic valve... 
clopidogrel | aspirin | aortic stenosis | bleeding | transcatheter aortic valve replacement | stroke | CARDIAC & CARDIOVASCULAR SYSTEMS | SINGLE | STENOSIS | DUAL-ANTIPLATELET THERAPY | PROTECTION | TAVI | CEREBROVASCULAR EVENTS | RISK | CONSENSUS DOCUMENT | ATRIAL-FIBRILLATION | PREDICTORS | transcatheter aortic valve replacement | South America | Humans | Male | Aortic Valve - surgery | Prosthesis Design | Aspirin - administration & dosage | Early Termination of Clinical Trials | Fibrinolytic Agents - adverse effects | Ischemic Attack, Transient - prevention & control | Time Factors | Aspirin - adverse effects | Ischemic Attack, Transient - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Aged, 80 and over | Ticlopidine - administration & dosage | Female | Thrombosis - prevention & control | Drug Therapy, Combination | Myocardial Infarction - etiology | Balloon Valvuloplasty - adverse effects | Platelet Aggregation Inhibitors - adverse effects | Transcatheter Aortic Valve Replacement - adverse effects | Transcatheter Aortic Valve Replacement - instrumentation | Stroke - prevention & control | Europe | Heart Valve Prosthesis | Risk Factors | Kaplan-Meier Estimate | Treatment Outcome | Ticlopidine - analogs & derivatives | Canada | Stroke - etiology | Thrombosis - etiology | Clopidogrel | Aged | Fibrinolytic Agents - administration & dosage | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Thrombosis - mortality | Transcatheter Aortic Valve Replacement - mortality | Thrombosis - diagnosis
Journal Article
Circulation, ISSN 0009-7322, 2010, Volume 122, Issue 25, pp. 2680 - 2687
Journal Article
The Lancet, ISSN 0140-6736, 2006, Volume 367, Issue 9526, pp. 1903 - 1912
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2010, Volume 56, Issue 20, pp. 1639 - 1643
Journal Article
Stroke, ISSN 0039-2499, 09/2016, Volume 47, Issue 9, pp. 2323 - 2330
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2015, Volume 114, Issue 2, pp. 403 - 409
As non-valvular atrial fibrillation (AF) brings a risk of stroke, oral anticoagulants (OAC) are recommended. In 'real world' clinical practice, many patients... 
Clopidogrel | Aspirin | Oral anti-coagulation | Warfarin | Edoxaban | Atrial fibrillation | clopidogrel | TRIALS | QUALITY | EFFICACY | RIVAROXABAN | APIXABAN | edoxaban | NETWORK METAANALYSIS | warfarin | ORAL ANTICOAGULANT DRUGS | atrial fibrillation | DABIGATRAN | NET CLINICAL BENEFIT | aspirin | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Anticoagulants - administration & dosage | Ticlopidine - therapeutic use | Humans | Risk | Thiazoles - administration & dosage | Thiazoles - therapeutic use | Thiazoles - adverse effects | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Thrombophilia - etiology | Pyridines - adverse effects | Vitamin K - antagonists & inhibitors | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Observational Studies as Topic | Ticlopidine - administration & dosage | Stroke - epidemiology | Aspirin - therapeutic use | Embolism - etiology | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Embolism - epidemiology | Thrombophilia - drug therapy | Platelet Aggregation Inhibitors - adverse effects | Pyridines - therapeutic use | Brain Ischemia - epidemiology | Cerebral Hemorrhage - chemically induced | Stroke - prevention & control | Embolism - prevention & control | Pyridines - administration & dosage | Risk Assessment | Mortality | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Brain Ischemia - prevention & control | Brain Ischemia - etiology | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Randomized Controlled Trials as Topic | Atrial Fibrillation - blood | Drug Synergism | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Numbers Needed To Treat | Cerebral Hemorrhage - epidemiology | Factor Xa Inhibitors - adverse effects
Journal Article
Stroke, ISSN 0039-2499, 05/2014, Volume 45, Issue 5, pp. 1248 - 1257
BACKGROUND AND PURPOSE—Severe atherosclerosis in the aortic arch is associated with a high risk of recurrent vascular events, but the optimal antithrombotic... 
Cerebral infarction | Aorta | Atherosclerosis | atherosclerosis | TRANSIENT ISCHEMIC ATTACK | PREVENTION | VASCULAR EVENTS | FOLLOW-UP | CLINICAL NEUROLOGY | RISK-FACTOR | cerebral infarction | DOUBLE-BLIND | ATHEROMAS | PERIPHERAL VASCULAR DISEASE | aorta | MATCH | Plaque, Atherosclerotic - mortality | Single-Blind Method | Prospective Studies | Anticoagulants - administration & dosage | Ticlopidine - pharmacology | Humans | Middle Aged | Aortic Diseases - mortality | Male | Plaque, Atherosclerotic - epidemiology | Warfarin - administration & dosage | Aspirin - administration & dosage | Embolism - drug therapy | Warfarin - pharmacology | Platelet Aggregation Inhibitors - administration & dosage | Aged, 80 and over | Platelet Aggregation Inhibitors - pharmacology | Ticlopidine - administration & dosage | Female | Stroke - epidemiology | Aspirin - pharmacology | Stroke - mortality | Drug Therapy, Combination | Embolism - epidemiology | Aorta, Thoracic - pathology | Brain Ischemia - epidemiology | Embolism - mortality | Aortic Diseases - epidemiology | Treatment Outcome | Stroke - drug therapy | Ticlopidine - analogs & derivatives | Aortic Diseases - drug therapy | Anticoagulants - pharmacology | Brain Ischemia - drug therapy | Aged | Brain Ischemia - mortality | Plaque, Atherosclerotic - drug therapy | Life Sciences | Human health and pathology
Journal Article
Stroke, ISSN 0039-2499, 05/2008, Volume 39, Issue 5, pp. 1482 - 1486
Background and Purpose-In ACTIVE-W, oral anticoagulation (OAC) was more efficacious than combined clopidogrel plus aspirin (C + A) in preventing vascular... 
Stroke | Anticoagulation | Atrial fibrillation | Risk stratification | atrial fibrillation | risk stratification | anticoagulation | ANTITHROMBOTIC THERAPY | PERIPHERAL VASCULAR DISEASE | stroke | BLOOD-PRESSURE | CLINICAL NEUROLOGY | Angiotensin II Type 1 Receptor Blockers - adverse effects | Anticoagulants - administration & dosage | Humans | Middle Aged | Clinical Protocols | Biphenyl Compounds - adverse effects | Warfarin - adverse effects | Male | Cerebral Hemorrhage - physiopathology | Warfarin - administration & dosage | Aspirin - administration & dosage | Aspirin - adverse effects | Tetrazoles - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Cerebral Hemorrhage - prevention & control | Ticlopidine - administration & dosage | Female | Drug Therapy, Combination | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Platelet Aggregation Inhibitors - adverse effects | Cerebral Hemorrhage - chemically induced | Stroke - prevention & control | Risk Assessment | Risk Factors | Atrial Fibrillation - complications | Treatment Outcome | Stroke - drug therapy | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Stroke - etiology | Biphenyl Compounds - administration & dosage | Aged | Tetrazoles - adverse effects | Drug Combinations | Index Medicus
Journal Article
Stroke, ISSN 0039-2499, 04/2019, Volume 50, Issue 4, pp. 947 - 953
BACKGROUND AND PURPOSE—The role of aspirin plus clopidogrel (A+C) therapy compared with aspirin monotherapy in patients presenting with acute ischemic stroke... 
clopidogrel | SHORT-TERM PROGNOSIS | EUROPEAN STROKE | transient ischemic attack | COLLABORATIVE METAANALYSIS | stroke | TIA | SECONDARY PREVENTION | CLINICAL NEUROLOGY | DIPYRIDAMOLE | DUAL ANTIPLATELET THERAPY | HIGH-RISK | MINOR STROKE | TIME-COURSE ANALYSIS | aspirin | PERIPHERAL VASCULAR DISEASE | Stroke (Disease) | Clopidogrel | Aspirin | Drug therapy, Combination | Drug therapy | Testing
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2010, Volume 9, Issue 5, pp. 489 - 497
Journal Article
Journal Article